ZLAB – zai lab limited - american depositary shares (US:NASDAQ)
Stock Stats
News
3/12
07:30 pm
zlab
Low
Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer
3/7
08:18 am
zlab
Low
Zai Lab Limited (NASDAQ: ZLAB) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $55.00 price target on the stock.
3/5
10:26 am
zlab
Low
Zai Lab Limited (NASDAQ: ZLAB) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
3/3
08:10 am
zlab
Medium
Zai Lab Limited (NASDAQ: ZLAB) had its "neutral" rating re-affirmed by analysts at Bank of America Co.. They now have a $36.10 price target on the stock, up previously from $29.00.
3/3
07:30 am
zlab
Medium
Zai Lab Announces Participation in Investor Conferences in March 2025
2/27/2025
06:00 am
ZLAB
-4.5%
MISS
2/27/2025
06:00 am
ZLAB
0.9%
MISS
2/27/2025
06:00 am
ZLAB
0.9%
MISS
2/27/2025
06:00 am
ZLAB
-4.5%
MISS
3/7
05:06 pm
Initiates
Sector Outperform
Scotiabank
Medium
-4.8%
3/7
05:06 pm
Initiates
Sector Outperform
Scotiabank
Medium
-4.8%
3/7
08:18 am
Initiates
Sector Outperform
Scotiabank
Low
1.7%
3/7
08:18 am
Initiates
Sector Outperform
Scotiabank
Low
1.7%
3/7
06:46 am
Initiates
OUTPERFORM
SCOTIABANK
Medium
3.8%
3/12
04:27 pm
zlab
Low
Form 4 Zai Lab Ltd For: Mar 10 Filed by: Du Ying
3/6
04:46 pm
zlab
Low
Form 4 Zai Lab Ltd For: Mar 05 Filed by: GAYNOR RICHARD
3/6
04:46 pm
zlab
Low
Form 4 Zai Lab Ltd For: Mar 04 Filed by: Du Ying
3/5
04:11 pm
zlab
Low
Form 144 Zai Lab Ltd Filed by: Du Ying
3/5
11:22 am
zlab
Low
Form 144 Zai Lab Ltd Filed by: GAYNOR RICHARD
Show more
Top News Gainers
1/23 Form 6-K Zai Lab Ltd For: Jan 22 14.5%
10/30 Zai Lab Announces Upcoming Presentations at November Conferences 12.5%
1/14 Zai Lab Appoints Lonnie Moulder to Board of Directors 9.3%
9/4 Zai Lab Ltd (NASDAQ: ZLAB) is now covered by analysts at China Renaissance Securities Ltd.. They set a "buy" rating on the stock. 6.7%
5/6 Form 424B2 Zai Lab Ltd 5.5%
12/27 Zai Lab Announces NMPA Approval of ZEJULA® (Niraparib) in China as Maintenance Therapy for Patients with Recurrent Ovarian Cancer 5.3%
10/25 Zai Lab Partner, MacroGenics, Announces Initiation of Phase 2/3 MAHOGANY Study of Margetuximab in Gastric or Gastroesophageal Junction Cancer 5.2%
1/12 Week In Review: 4 China Biopharmas Announce $100+ Million Deals In First Week Of 2020 [Seeking Alpha] 5.0%
4/8 Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody) 5.0%
2/10 Zai Lab Announces Acceptance of NDA Submission of Omadacycline in China by the NMPA 5.0%
Top News Decliners
3/16 Form 6-K Zai Lab Ltd For: Mar 16 -12.6%
8/27 Zai Lab Ltd (NASDAQ: ZLAB) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -7.4%
12/16 Zai Lab Announces the Appointment of Timothy Yap, M.D., Ph.D., to its Scientific Advisory Board -6.0%
1/21 Form POSASR Zai Lab Ltd -5.8%
5/16 Zai Lab Announces CTA Approval to Initiate a Phase 3 Clinical Trial of ETX2514SUL for the Treatment of Carbapenem-Resistant Acinetobacter Infections -4.8%
4/30 Zai Lab Announces Upcoming Participation in the BofA Securities 2020 Health Care Conference -4.5%
8/12 China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China -3.7%
3/19 Zai Lab's (ZLAB) CEO Samantha Du on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -3.2%
6/28 Zai Lab Ltd (NASDAQ: ZLAB) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating. -2.6%
4/27 Zai Lab Ltd (NASDAQ: ZLAB) is now covered by analysts at Goldman Sachs Group Inc. They set a "buy" rating on the stock. -2.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3